UnitedHealth Group (NYSE:UNH) held its annual investor conference last week to provide business updates. The key takeaway from the conference was that the health insurance provider expects to exhibit slower growth in 2013 due to a decline in fully insured commercial customers. The reason attributed to this expected decline is more businesses are seen covering healthcare costs themselves even as they hire the company to manage healthcare benefits. However, the company does expect to add 3.5 million-4 million new members on back of continued growth in other businesses including Medicare Advantage healthcare and commercial fee-based plans. 
We are analyzing the impact of UnitedHealth’s observations and will soon be updating our model and price estimate for the company, which currently stands at $70, to reflect these developments.
We, however, are still bullish on the company’s prospects going forward as re-election of Barack Obama as the U.S. president will only help re-enforce The Patient Protection and Affordable Care Act (“PPACA”) that will allow the company to meaningfully increase its enrollments over the next four years. We will be writing a follow-up article to discuss the same in detail.
- UnitedHealth Mid Year Review: How Did Optum Perform In The First Six Months Of 2016?
- UnitedHealth Mid Year Review: Stock Up 15% YTD On Robust Optum Growth, Raised Guidance
- UnitedHealth Posts Robust Q2 Results On Solid Optum Performance
- What To Expect From UnitedHealth’s Q2 Results
- How Important Is Optum For UnitedHealth?
- How Much Does OptumRx Contribute To UnitedHealth Group’s Revenues & Growth?
Meanwhile, using our interactive charts, you can see how a change in its market share in private insurance business (which in-turn affects the number of enrollments) impacts our price estimate.